Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent fluticasone propionate cream plus emollient for relapse prevention in pediatric atopic dermatitis
2017-001574-42Phase 4
- Sponsor
- GSK
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluticasone propionate in atopic dermatitis (AD) (2 arms), sponsored by GSK. Primary endpoint: Time to first relapse of atopic dermatitis.
02
Drugs
fluticasone propionate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2017-001574-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001574-42.